Mortality in Parkinson's disease: A systematic review and meta‐analysis

Cited by (331)

Items 101–200 of 331

  1. Respiratory Disorders in Parkinson’s Disease
    Evelyn Maria Guilherme, Roberta de Fátima Carreira Moreira, Adriele de Oliveira, Alyne Montero Ferro, Valéria Amorim Pires Di Lorenzo, Anna Carolyna L. Gianlorenço · 2021 · Journal of Parkinson s Disease
  2. Mortality and Its Risk Factors in Patients with Rapid Eye Movement Sleep Behavior Disorder
    Junying Zhou, Jihui Zhang, Siu Ping Lam, Vincent Mok, Anne Y. Y. Chan, Shirley Xin Li, Yaping Liu, Xiangdong Tang, Wing‐Ho Yung, Yun Kwok Wing · 2016 · SLEEP
  3. Identifying Protective Drugs for Parkinson's Disease in Health‐Care Databases Using Machine Learning
    Émeline Courtois, Thi Thu Ha Nguyen, Agnès Fournier, Laure Carcaillon‐Bentata, E. Moutengou, Sylvie Escolano, Pascale Tubert‐Bitter, Alexis Elbaz, Anne C. M. Thiébaut, Ismaïl Ahmed · 2022 · Movement Disorders
  4. Access to End-of Life Parkinson's Disease Patients Through Patient-Centered Integrated Healthcare
    Carsten Eggers, Richard Dano, Juliane Schill, Gereon R. Fink, Lars Timmermann, Raymond Voltz, Heidrun Golla, Stefan Lorenzl · 2018 · Frontiers in Neurology
  5. Glymphatic system dysfunction as a biomarker of disease progression in Parkinson’s disease: neuroimaging evidence from longitudinal cohort studies
    Junli Ren, Dongling Xie, Lingsheng Wang, Zihao Wu, Shenyi Lin, Qiaoqiao Jin, Yuwen Luo, Baoyi Zhu, Haoyang Huang, Junchao Wang et al. · 2025 · Journal of Neurology
  6. Accuracy of death certificates for recording parkinsonian syndromes and associated dementia
    Hanxu Shi, Carl E Counsell · 2020 · Journal of Neurology
  7. Cognitive anosognosia is associated with frontal dysfunction and lower depression in Parkinson’s disease
    Han Soo Yoo, Seok Jong Chung, Yang Hyun Lee, Byoung Seok Ye, Young H. Sohn, Phil Hyu Lee · 2020 · European Journal of Neurology
  8. Outcome of Hospitalized Parkinson's Disease Patients with and without COVID ‐19
    Raminder Parihar, Victor Ferastraoaru, Aristea S. Galanopoulou, Howard L. Geyer, David Myland Kaufman · 2021 · Movement Disorders Clinical Practice
  9. Living and dying with Parkinson's disease
    George Webster Ross, Robert D. Abbott · 2014 · Movement Disorders
  10. What is the Parkinson Pandemic?
    Roger L. Albin, Nikolas Grotewold · 2023 · Movement Disorders
  11. Has Deep Brain Stimulation Changed the Very Long‐Term Outcome of Parkinson's Disease? A Controlled Longitudinal Study
    Philipp Mahlknecht, Marina Peball, Katherina J. Mair, Mario Werkmann, Michael Nocker, Elisabeth Wolf, Wilhelm Eisner, Sweta Bajaj, Sebastian Quirbach, Cecilia Peralta et al. · 2020 · Movement Disorders Clinical Practice
  12. Why Palliative Care Applies to Parkinson's Disease
    Raquel Bouça‐Machado, Herma H. Lennaerts, Bastiaan R. Bloem, Joaquim José Ferreira · 2018 · Movement Disorders
  13. Effects of socioeconomic status on mortality after Parkinson's disease: A nationwide population-based matched cohort study in Korean populations
    Seo Yeon Yoon, Jaeyong Shin, Jee Suk Chang, Sang Chul Lee, Yong Wook Kim · 2020 · Parkinsonism & Related Disorders
  14. Present and Future of Parkinson’s Disease in Spain: PARKINSON-2030 Delphi Project
    Diego Santos‐García, Marta Blázquez Estrada, Matilde Calopa, Francisco Escamilla Sevilla, Eric Freire, Pedro Ruiz, Francisco Grandas, Jaime Kulisevsky, Lydia López Manzanares, Juan Carlos Martínez‐Castrillo et al. · 2021 · Brain Sciences
  15. Consensus-Based Recommendations for Advance Directives of People with Parkinson’s Disease in Regard to Typical Complications by German Movement Disorder Specialists
    Martin Klietz, Johanna M. Berndt, Florian Wegner, Nils Schneider, Günter U. Höglinger, Carsten Eggers, Stephanie Stiel · 2020 · Journal of Clinical Medicine
  16. Improving mobile health apps usage: a quantitative study on mPower data of Parkinson's disease
    Jiexun Li, Xiaohui Chang · 2020 · Information Technology and People
  17. Incidence and Mortality of Parkinson’s Disease in Estonia
    Liis Kadastik‐Eerme, Nele Taba, Toomas Asser, Pille Taba · 2019 · Neuroepidemiology
  18. The elephant in the room: critical reflections on mortality rates among individuals with Parkinson’s disease
    Lisanne J. Dommershuijsen, Sirwan K.L. Darweesh, Yoav Ben‐Shlomo, Benzi M. Kluger, Bastiaan R. Bloem · 2023 · npj Parkinson s Disease
  19. The introduction of a Parkinson’s disease email alert system to allow for early specialist team review of inpatients
    Peter Hobson, Sally Roberts, Glesni Davies · 2019 · BMC Health Services Research
  20. Beyond 10 years of levodopa intestinal infusion experience: Analysis of mortality and its predictors
    Carlo Alberto Artusi, Roberta Balestrino, Gabriele Imbalzano, Sara Bortolani, Elisa Montanaro, Sara Tuttobene, Margherita Fabbri, Maurizio Zibetti, Leonardo Lopiano · 2019 · Parkinsonism & Related Disorders
  21. Approaching the Gut and Nasal Microbiota in Parkinson’s Disease in the Era of the Seed Amplification Assays
    Alessandra Consonni, Martina Miglietti, Chiara Maria Giulia De Luca, Federico Angelo Cazzaniga, Arianna Ciullini, Ilaria Linda Dellarole, Giuseppe Bufano, Alessio Di Fonzo, Giorgio Giaccone, Fulvio Baggi et al. · 2022 · Brain Sciences
  22. Air pollution exposure and mortality from neurodegenerative diseases in the Netherlands: A population-based cohort study
    Susan Peters, Femke Bouma, Gerard Hoek, Nicole Janssen, Roel C.H. Vermeulen · 2024 · Environmental Research
  23. Association between Parkinson’s Disease and Psychosocial Factors: Results of the Nationally Representative German Ageing Survey
    Regina Vardanyan, Hans‐Helmut König, André Hajek · 2022 · Journal of Clinical Medicine
  24. Time Trends of the Incidence, Prevalence, and Mortality of Parkinsonism
    Jessica J. Wong, Jeffrey C. Kwong, Karen Tu, Debra A. Butt, Ray Copes, Andrew S. Wilton, Brian James Murray, Alexander Kopp, Hong Chen · 2019 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  25. Association of Dynamic Changes in Metabolic Syndrome Status with the Risk of Parkinson’s Disease: A Nationwide Cohort Study
    Sang Hyun Park, Ga Eun Nam, Kyungdo Han, Youn Huh, Wonsock Kim, Minkyung Lee, Eun-Sil Koh, Eun Sook Kim, Mee Kyung Kim, Hyuk‐Sang Kwon et al. · 2021 · Journal of Parkinson s Disease
  26. Parkinson's disease patients may have higher rates of Covid-19 mortality in Iran
    Mehri Salari, Masoud Etemadifar, Farzad Ashrafi, Davood Ommi, Zahra Aminzade, Sepand Tehrani Fateh · 2021 · Parkinsonism & Related Disorders
  27. Association of ATG5 gene polymorphism with Parkinson’s disease in a Han Chinese population
    Jing Han, Ganghua Feng, Jibao Wu, Yi Zhang, Zhipeng Long, Xiaoxi Yao · 2021 · Acta Neurologica Belgica
  28. Survival in patients with Parkinson’s disease: a ten-year follow-up study in northern China
    Song Wang, Tao Li, Tingting Zhou, Lanlan Pu, Haiyang Wang, Xiaoxue Yin, Xinqing Hao, Lu Ren, Zhanhua Liang · 2022 · BMC Neurology
  29. Characterizing Complications of Deep Brain Stimulation Devices for the Treatment of Parkinsonian Symptoms Without Tremor: A Federal MAUDE Database Analysis
    Josiah Bennett, Jack MacGuire, Ena Novakovic, Huey Huynh, Keri Jones, Julian Lassiter Gendreau, Antonios Mammis, Mickey Ellis Abraham · 2021 · Cureus
  30. Does deep brain stimulation of the subthalamic nucleus prolong survival in Parkinson's Disease?
    Maria Fiorella Contarino, Johan Marinus, Jacobus Johannes van Hilten · 2018 · Movement Disorders
  31. Tradução e adaptação cultural do swallowing disturbance questionnaire para o português-brasileiro
    A. Jean Ayres, Marciéle Ghisi, Carlos Roberto de Mello Rieder, Yael Manor, Maira Rozenfeld Olchik · 2016 · Revista CEFAC
  32. Effects of physician visit frequency for Parkinson’s disease treatment on mortality, hospitalization, and costs: a retrospective cohort study
    Takako Fujita, Akira Babazono, Sung A Kim, Aziz Jamal, Yunfei Li · 2021 · BMC Geriatrics
  33. Associations of Young Adult Intelligence, Education, Height, and Body Mass Index with Subsequent Risk of Parkinson’s Disease and Survival: A Danish Cohort Study
    Merete Osler, Gunhild Tidemann Okholm, Marie Villumsen, Maarten Pieter Rozing, Terese Sara Høj Jørgensen · 2022 · Journal of Parkinson s Disease
  34. Morbidity Milestones Demonstrate Long Disability‐Free Survival in Parkinson's Disease Patients with Deep Brain Stimulation of the Subthalamic Nucleus
    Nils Schnalke, Agni Konitsioti, Anika K. Frank, Martin Kurz, Witold Henryk Polanski, Peter Themann, Martin Wolz, Stephan B. Sobottka, Heinz Reichmann, Björn H. Falkenburger et al. · 2023 · Movement Disorders Clinical Practice
  35. 40-Year Incidence of Early-Onset Parkinson’s Disease in Southeast Minnesota
    Emanuele Camerucci, Aidan F. Mullan, Pierpaolo Turcano, James H. Bower, Capucine Piat, J. Eric Ahlskog, Rodolfo Savica · 2023 · Journal of Parkinson s Disease
  36. Curcumin as a potential therapeutic agent for Parkinson’s disease: a systematic review
    Yu-Hsien Chang · 2025 · Frontiers in Pharmacology
  37. Relationship between plasma NFL and disease progression in Parkinson’s disease: a prospective cohort study
    Ruwei Ou, Kuncheng Liu, Junyu Lin, Tianmi Yang, Yi Xiao, Qianqian Wei, Yanbing Hou, Chunyu Li, Lingyu Zhang, Zheng Jiang et al. · 2023 · Journal of Neurology
  38. A simple-to-use web-based calculator for survival prediction in Parkinson’s disease
    Yunliang Tang, Jiao Wang, Gengfa Chen, Wen Ye, Nao Yan, Zhen Feng · 2021 · Aging
  39. New Structures in Neurology: Palliative Care for Neurological Patients
    Heidrun Golla, Gereon R. Fink, Roman Rolke, Stefan Lorenzl, Markus Ebke, Thomas Montag, Ralf Gold, Gereon Nelles, Carsten Eggers, Raymond Voltz · 2017 · Neurology International Open
  40. Case‐Fatality Rate in Parkinson's Disease: A Nationwide Registry Study
    Jussi Sipilä, Valtteri Kaasinen, Päivi T. Rautava, Ville Kytö · 2023 · Movement Disorders Clinical Practice
  41. Ten-Year Relative Survival From the Diagnosis of Parkinson's Disease: A Nationwide Database Study
    Han Gil Seo, Seong Jun Byun, Byung‐Mo Oh, Sang Jun Park · 2020 · Journal of the American Medical Directors Association
  42. Effects of cannabinoids in Parkinson’s disease animal models: a systematic review and meta-analysis
    Berzenn Urbi, Yunjoo Lee, Ian Paul Hughes, Sarah Thorning, Simon Broadley, Arman Sabet, Saman Heshmat · 2022 · BMJ Open Science
  43. Effect of deep brain stimulation compared with drug therapy alone on the progression of Parkinson’s disease
    Wenwen Dong, Chang Qiu, Yue Lu, Bei Luo, Xu Jiang, Lei Chang, Jiuqi Yan, Jian Sun, Weiguo Liu, Li Zhang et al. · 2024 · Frontiers in Neuroscience
  44. Advance Directives of German People with Parkinson’s Disease Are Unspecific in regard to Typical Complications
    Martin Klietz, Özlem Öcalan, Nils Schneider, Dirk W. Dressler, Stephanie Stiel, Florian Wegner · 2019 · Parkinson s Disease
  45. Risk of Mortality Associated With Atypical Antipsychotic use: A National Cohort Study of Older Adults With Depression and Parkinson's Disease
    Farid Chekani, Holly Michelle Holmes, Michael L. Johnson, Hua Chen, Jeffrey T. Sherer, Rajender R. Aparasu · 2020 · American Journal of Geriatric Psychiatry
  46. Epidemiology of Parkinson's Disease
    Mjid Oukhrib, Lahcen Tamegart, Hafida El Ghachi, Abdelali Ben Maloui, Bilal El‐Mansoury, Mohamed Chraa, Halima Gamrani · 2023 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  47. Association between osteoarthritis and the incidence of Parkinson’s disease in the United Kingdom
    Louis Jacob, Lee Smith, Ai Koyanagi, Alexis Schnitzler, Jae Il Shin, Karel Kostev · 2021 · Clinical Parkinsonism & Related Disorders
  48. Factors associated with mortality in early stages of parkinsonism
    Anouke van Rumund, Rianne A.J. Esselink, Marjolein B. Aerts, Markus Otto, Bastiaan R. Bloem, Marcel M. Verbeek · 2022 · npj Parkinson s Disease
  49. Mortality rates and proximal causes of death in patients with Lewy body dementia versus Alzheimer's disease: A longitudinal study using secondary care mental health records
    Anne D. Kershenbaum, Annabel C. Price, Rudolf N. Cardinal, Shanquan Chen, James Fitzgerald, Jonathan Lewis, Sinéad Moylett, John Tiernan O'Brien · 2023 · International Journal of Geriatric Psychiatry
  50. Mortalidade Hospitalar na Doença de Parkinson: Análise Retrospetiva num Hospital Terciário Português
    Joana Martins, Adriana Rua, Nuno Vila Chã · 2016 · Acta Médica Portuguesa
  51. Survival in Parkinson's disease in relation to striatal dopamine transporter binding
    Elina Mäkinen, Juho Joutsa, Tero J. Vahlberg, Valtteri Kaasinen · 2017 · Parkinsonism & Related Disorders
  52. Prospective comorbidity-matched study of Parkinson's disease and risk of mortality among women
    Anke C. Winter, Pamela M. Rist, Julie E. Buring, Tobias Kurth · 2016 · BMJ Open
  53. Serum alpha klotho levels in Parkinson’s Disease
    Ahmet Yalçın, Emine Gemci, Busra Yurumez, Rezzak Yılmaz, Murat Varlı, Volkan Atmış, Muhittin Cenk Akbostancı, Nuray Yazıhan · 2024 · Neurological Sciences
  54. Fixed-Life or Rechargeable Batteries for Deep Brain Stimulation: Preference and Satisfaction Among Patients With Hyperkinetic Movement Disorders
    Xian Qiu, Yuhan Wang, Zhengyu Lin, Yunhao Wu, Wenying Xu, Yiwen Wu, Bomin Sun, Keyoumars Ashkan, Chencheng Zhang, Dianyou Li · 2021 · Frontiers in Neurology
  55. The Impact of Sex‐Specific Survival on the Incidence of Dementia in Parkinson's Disease
    Anne Fink, Richard C. Dodel, Daniela Georges, Gabriele Doblhammer · 2023 · Movement Disorders
  56. Instrumentos de avaliação clínica para disfagia orofaríngea na doença de Parkinson: revisão sistemática
    A. Jean Ayres, Laís Alves Jacinto-Scudeiro, Maira Rozenfeld Olchik · 2017 · Audiology - Communication Research
  57. Genetically Predicted Levels of Circulating Inflammatory Cytokines and the Risk and Age at Onset of Parkinson’s Disease: A Two-Sample Mendelian Randomization Study
    Yating Zhao, Xiaoqian Zhang, Na Guo, Dandan Tian, Chenguang Zhang, Changqing Mu, Chen Han, Ruixia Zhu, Jian Zhang, Xu Liu · 2022 · Frontiers in Aging Neuroscience
  58. Palliativmedizinische Versorgung neurologischer Patienten
    Heidrun Golla, Gereon R. Fink, Roman Rolke, Stefan Lorenzl, Markus Ebke, Thomas Montag, Ralf Gold, Gereon Nelles, Carsten Eggers, Raymond Voltz · 2017 · Aktuelle Neurologie
  59. Frozen Shoulder and the Risk of Parkinson’s Disease: A Danish Registry-Based Cohort Study
    Nadia R Gadgaard, Katalin Veres, Victor W. Henderson, Alma B Pedersen · 2024 · Clinical Epidemiology
  60. Early-Onset Parkinson’s Disease: Unique Features and Management Approaches
    Jordan L. Hickman, Andrew Tsai, Michelle E. Fullard, Michael Korsmo, Emily Forbes, Sana Aslam, Alexander J. Baumgartner, Jeanne Feuerstein, Ece Bayram · 2025 · Current Neurology and Neuroscience Reports
  61. Current Status of Acceptance of Disability and the Correlation With the Life Quality in Parkinson's Disease in Southwest China
    Yan Liang, Dezhi Chen, Ruwei Ou, Bi Zhao, Wei Song, Xiaojiang Yi, Rong Yang, Xueping Chen · 2022 · Frontiers in Medicine
  62. Association between Respiratory Function and Motor Function in Different Stages of Parkinson’s Disease
    Chong Xi, Xiao-Chen Bai, Ce Li, Weining Wang, Shan Tian, Yilin Tang, Bo Shen, Jian Wang, Yimin Sun, Yulian Zhu · 2023 · European Neurology
  63. Cognitive deficits in Parkinson’s disease: current perspectives
    Jeremy Cosgrove, Jane Alty · 2018 · Journal of Parkinsonism and Restless Legs Syndrome
  64. Estimulación cerebral profunda en enfermedad de Parkinson
    Universidad Tecnológica de Pereira, Daniel S. Marín‐Medina, Juan Felipe Quintero-Moreno, Universidad Tecnológica de Pereira, Aníbal Valencia-Vásquez, Universidad Tecnológica de Pereira, C Duque-Salazar, Universidad Tecnológica de Pereira, AF Gil-Restrepo, Universidad Tecnológica de Pereira et al. · 2018 · IATREIA
  65. Gender differences in diagnostic tools, medication, time to medication, and nonmotor symptoms in Parkinsonian patients
    Örjan Skogar, Mats Nilsson, Johan Lökk · 2022 · Brain Circulation
  66. Progressive supra-nuclear palsy: frequency of cardinal extrapyramidal features at first presentation
    Sunil Pradhan, Ruchika Tandon · 2015 · Postgraduate Medical Journal
  67. Socioeconomic area deprivation and its relationship with dementia, Parkinson's Disease and all-cause mortality among UK older adults: a multistate modeling approach
    May A. Beydoun, Michael F. Georgescu, Jordan Weiss, Nicole Noren Hooten, Hind A. Beydoun, Jack Tsai, Christian A. Maino Vieytes, Michele K. Evans, Alan B. Zonderman · 2025 · Social Science & Medicine
  68. Palliative care in Parkinson disease and related disorders
    Jennifer Corcoran, Andrew P. Huang, Janis M. Miyasaki, Christopher G. Tarolli · 2023 · Handbook of clinical neurology
  69. Tinetti balance performance is associated with mortality in older adults with late-onset Parkinson’s disease: a longitudinal study
    Louise Chang Laurent, Pierre Koskas, Janina Estrada, Mélanie Sebbagh, Sophie Lacaille, Agathe Raynaud-Simon, Matthieu Lilamand · 2023 · BMC Geriatrics
  70. A Post-Authorization Safety Study of Quetiapine as Antidepressant Treatment in Sweden: Nested Case–Control Analyses of Select Outcomes
    Johan Reutfors, Philip Brenner, Bob Brody, Heather Wray, Morten Tolstrup Andersen, Lena Brandt · 2019 · Drug Safety
  71. Parkinson’s disease disrupts the ability to initiate and apply episodic foresight
    Sarah P. Coundouris, Julie D. Henry, Peter G. Rendell, Alexander Lehn · 2022 · Journal of the International Neuropsychological Society
  72. Analysis of Parkinson’s Disease Outpatient Counselling for Advance Directive Creation: A Cross-Sectional Questionnaire-Based Survey of German General Practitioners and Neurologists
    Ida Jensen, Almut Bretschneider, Stephanie Stiel, Florian Wegner, Günter U. Höglinger, Martin Klietz · 2022 · Brain Sciences
  73. Comparison of the effectiveness, safety, and costs of anti‐Parkinson drugs: A multiple‐center retrospective study
    Wenting Li, Hua Zhang, Yuan Zhang, Ke Wang, Jiaojiao Hui, Zhan‐Miao Yi · 2023 · CNS Neuroscience & Therapeutics
  74. Remote-Messung bei idiopathischem Parkinson-Syndrom
    Urs Kleinholdermann, Johannes Werner Melsbach, David José Pedrosa · 2019 · Der Nervenarzt
  75. Ethnic and Immigrant Variations in the Time Trends of Dementia and Parkinsonism
    Jessica J. Wong, Jeffrey C. Kwong, Karen Tu, Debra A. Butt, Andrew S. Wilton, Baiju R. Shah, Brian James Murray, Alexander Kopp, Hong Chen · 2021 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  76. ComputAgeBench: Epigenetic Aging Clocks Benchmark
    Dmitrii V. Kriukov, Evgeniy Efimov, Ekaterina Kuzmina, Anastasiia Dudkovskaia, Ekaterina E. Khrameeva, Dmitry V. Dylov · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  77. Hospitalization and mortality from Parkinson’s Disease in Brazil from 2008 to 2020
    Paula Renata Olegini Vasconcellos, Maria Lúcia Frizon Rizzotto, Marcelo Taglietti · 2023 · Saúde em Debate
  78. Serum 25-hydroxyvitamin D concentrations and their impact on all-cause mortality in Parkinson’s disease: insights from National Health and Nutrition Examination Survey 1999–2020 data
    Yufei Yong, Hui Dong, Zhen Zhou, Yan Zhu, Meiling Gu, Wenxiao Li · 2024 · Frontiers in Nutrition
  79. Comparative Analysis of the Incidence, Prevalence, and Survival of 8 Types of Parkinsonism in a Population‐Based Study with 367 Million Person Years of Observation over 21 Years
    Sacha E. Gandhi, Katherine A. Grosset, Prasanth A. Iruthayaraj, Romel Gravesande, Lance Lee, Cathal Doyle, Yoav Ben‐Shlomo, Donald G. Grosset · 2025 · Movement Disorders Clinical Practice
  80. Impact of REM Sleep Behavior and Sleep Talking on Mortality in Parkinson's Disease
    Eemil Partinen, Ari Ylikoski, Mariusz Siemiński, Markku Partinen · 2024 · Cureus
  81. The treatment gap for deep brain stimulation in Parkinson’s disease: a comparative analysis of cost and utilisation in high-income countries
    Athena Stein, Nathan Higgins, Mehul Gajwani, Christian A. Gericke · 2024 · Australian Health Review
  82. Cardiovascular outcomes in Parkinson’s disease patients from a retrospective cohort study
    Subin Lim, Yunjin Yum, Jong-Ho Kim, Chan‐Nyoung Lee, Hyung Joon Joo, Do-Young Kwon · 2024 · Scientific Reports
  83. Sex‐Dependent Improvement in Survival of Parkinson's Disease Patients
    Tomi Kuusimäki, Samu H. Kurki, Jussi Sipilä, Heli Salminen‐Mankonen, Olli Carpén, Valtteri Kaasinen · 2020 · Movement Disorders Clinical Practice
  84. Morbidade hospitalar e mortalidade por Doença de Parkinson no Brasil de 2008 a 2020
    Paula Renata Olegini Vasconcellos, Maria Lúcia Frizon Rizzotto, Marcelo Taglietti · 2023 · Saúde em Debate
  85. Cost-effectiveness analysis of insecticide ban aimed at preventing Parkinson's disease in Central California
    Shiwen Li, Roch A. Nianogo, Yuyuan Lin, Hanwen Wang, Yu Yu, Kimberly C. Paul, Beate R. Ritz · 2023 · The Science of The Total Environment
  86. Corydaline alleviates Parkinson’s disease by regulating autophagy and GSK-3β phosphorylation
    Kaikai Zhou, Shasha Xu · 2024 · Psychopharmacology
  87. Clinical and Economic Insights into Parkinson’s Disease Hospitalization: A Comprehensive Study of 19,719 Inpatient Cases in Hubei Province, China
    Wen Liu, Pan Nie, Jibo Zhang, Da Zhou, Jie Zhang, Jincao Chen · 2024 · Neuroepidemiology
  88. Independence of Coping Styles With the Patient–Doctor Relationship and Shared Decision-Making in People With Parkinson’s Disease
    Cynthia Sarabia-Tapia, Teresa Corona, Susana López-Alamillo, Etienne Reséndiz-Henríquez, Amin Cervantes‐Arriaga, Mayela Rodríguez‐Violante · 2020 · Journal of Patient Experience
  89. Advances in artificial neural networks as a disease prediction tool
    Taylor MA, Bennett Cl, Schoen MW, Hoque S · 2021 · Journal of Cancer Research & Therapy
  90. The predictive relationships between advanced dynamic balance and physical activity/quality of life in Parkinson's disease
    Sz-Yan Wu, Tsu‐Kung Lin, Chien‐Yu Pan, Chia‐Liang Tsai · 2023 · Human Movement Science
  91. Assessment of the Status of Patients with Parkinson’s Disease Using Neural Networks and Mobile Phone Sensors
    Yulia Alexandrovna Shichkina, Elizaveta Stanevich, Yulia Irishina · 2020 · Diagnostics
  92. Morbus Parkinson im Alter
    Rüdiger Lange, Frank Joachim Erbguth · 2017 · Zeitschrift für Gerontologie und Geriatrie
  93. Long‐Term Medication Profiles in Parkinson's Disease under Subthalamic Deep Brain Stimulation: A Controlled Study
    Christoph Theyer, V. Beliveau, F. Krismer, M. Peball, K. Mair, B. Heim, A. Djamshidian, S. Kiechl, Wilhelm Eisner, S. Eschlböck et al. · 2024 · Movement Disorders Clinical Practice
  94. Prediction of all-cause mortality in Parkinson’s disease with explainable artificial intelligence using administrative healthcare data
    Yu Hyun Park, Yong Wook Kim, Dae Ryong Kang, Sang Chul Lee, Seo Yeon Yoon · 2025 · npj Parkinson s Disease
  95. Prognosis in Parkinson's Disease: An Individual Patient Data Meta‐Analysis of Six European Incidence Cohorts
    Angus D. Macleod, David J. McLernon, Marta Camacho, Caroline H. Williams‐Gray, Rachael Ashleigh Lawson, Alison Jane Yarnall, David C. Bäckström, Lars Forsgren, Jodi Maple‐Grødem, Guido Werner Alves et al. · 2026 · Movement Disorders
  96. Temporal trend of mortality due to Parkinson’s disease in older people in Brazil, 2002-2021
    Thamara Hübler Figueiró, Viviane Nogueira de Zorzi, Eleonora d’Orsi, Cassiano Ricardo Rech, Danúbia Hillesheim · 2024 · Epidemiologia e Serviços de Saúde
  97. Mortality in Iranian Patients with Parkinson’s Disease: Cumulative Impact of Cardiovascular Comorbidities as One Major Risk Factor
    Seyed‐Mohammad Fereshtehnejad, Azadeh Shafieesabet, Mahdiyeh Shafieesabet, Gholam Ali Shahidi, Ahmad Delbari, Johan Lökk · 2015 · Parkinson s Disease
  98. Parkinson’s Disease and Aging
    Julie Kay Andersen, Shankar J. Chinta · 2015 · Springer eBooks
  99. The Natural History of Parkinson’s Disease
    Miguel M Coelho, Joaquim José Ferreira · 2017 · Springer eBooks
  100. High incidence of dementia in Faroese‐born female residents in Denmark
    Maria Skaalum Petersen, Søren Lophaven, Pál Weihe, Elsebeth Lynge · 2020 · Alzheimer s & Dementia Translational Research & Clinical Interventions